These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31221673)

  • 41. A Rare Case Report of B-Cell Acute Lymphoblastic Leukemia with EP300::ZNF384 Fusion Gene.
    Wu X; Yang X; Chen Y; Zhang Z; XinhongYang
    Clin Lab; 2024 Jun; 70(6):. PubMed ID: 38868890
    [No Abstract]   [Full Text] [Related]  

  • 42. Mixed-phenotype acute leukemia relapse in the iris.
    Shildkrot Y; Onciu M; Hoehn ME; Wilson MW
    J AAPOS; 2010 Oct; 14(5):453-4. PubMed ID: 20863726
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12;21)(p13;q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol.
    Barbany G; Andersen MK; Autio K; Borgström G; Franco LC; Golovleva I; Heim S; Heinonen K; Hovland R; Johansson B; Johannsson JH; Kjeldsen E; Nordgren A; Palmqvist L; Forestier E; ; ;
    Leuk Res; 2012 Jul; 36(7):936-8. PubMed ID: 22521551
    [No Abstract]   [Full Text] [Related]  

  • 44. Runx1 is essential at two stages of early murine B-cell development.
    Niebuhr B; Kriebitzsch N; Fischer M; Behrens K; Günther T; Alawi M; Bergholz U; Müller U; Roscher S; Ziegler M; Buchholz F; Grundhoff A; Stocking C
    Blood; 2013 Jul; 122(3):413-23. PubMed ID: 23704093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular cytogenetics studies reveal unexpected chromosomal inversion as variant of t(12;21)(p13;q22) in child with B-cell precursor acute lymphoblastic leukemia.
    Ney-Garcia DR; Liehr T; Bhatt S; de Souza MT; de Matos RR; Binato R; Jordy FC; Abdelhay E; Ribeiro RC; Silva ML
    Leuk Lymphoma; 2012 Feb; 53(2):342-4. PubMed ID: 21848362
    [No Abstract]   [Full Text] [Related]  

  • 46. Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment.
    Dong L; Yu WM; Zheng H; Loh ML; Bunting ST; Pauly M; Huang G; Zhou M; Broxmeyer HE; Scadden DT; Qu CK
    Nature; 2016 Nov; 539(7628):304-308. PubMed ID: 27783593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intrauterine monoclonal origin of neonatal concordant acute lymphoblastic leukemia in monozygotic twins.
    Mahmoud HH; Ridge SA; Behm FG; Pui CH; Ford AM; Raimondi SC; Greaves MF
    Med Pediatr Oncol; 1995 Feb; 24(2):77-81. PubMed ID: 7990767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia.
    Sanjuan-Pla A; Bueno C; Prieto C; Acha P; Stam RW; Marschalek R; Menéndez P
    Blood; 2015 Dec; 126(25):2676-85. PubMed ID: 26463423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis.
    Haddox CL; Mangaonkar AA; Chen D; Shi M; He R; Oliveira JL; Litzow MR; Al-Kali A; Hogan WJ; Elliott MA
    Blood Cancer J; 2017 Sep; 7(9):e607. PubMed ID: 29016570
    [No Abstract]   [Full Text] [Related]  

  • 50. Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia.
    Oberley MJ; Gaynon PS; Bhojwani D; Pulsipher MA; Gardner RA; Hiemenz MC; Ji J; Han J; O'Gorman MRG; Wayne AS; Raca G
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27265. PubMed ID: 29797659
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel SSBP2-JAK2 fusion gene resulting from a t(5;9)(q14.1;p24.1) in pre-B acute lymphocytic leukemia.
    Poitras JL; Dal Cin P; Aster JC; Deangelo DJ; Morton CC
    Genes Chromosomes Cancer; 2008 Oct; 47(10):884-9. PubMed ID: 18618714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6-RUNX1: concordant results using quantitation of fusion transcript and flow cytometry.
    Alm SJ; Engvall C; Asp J; Palmqvist L; Abrahamsson J; Fogelstrand L
    Int J Lab Hematol; 2017 Apr; 39(2):121-128. PubMed ID: 28004528
    [TBL] [Abstract][Full Text] [Related]  

  • 53. E2A-Pbx1 induces growth, blocks differentiation, and interacts with other homeodomain proteins regulating normal differentiation.
    Kamps MP
    Curr Top Microbiol Immunol; 1997; 220():25-43. PubMed ID: 9103673
    [No Abstract]   [Full Text] [Related]  

  • 54. Expression of p53 N-terminal isoforms in B-cell precursor acute lymphoblastic leukemia and its correlation with clinicopathological profiles.
    Oh L; Hainaut P; Blanchet S; Ariffin H
    BMC Cancer; 2020 Feb; 20(1):110. PubMed ID: 32041553
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Durable remissions in
    Mouttet B; Vinti L; Ancliff P; Bodmer N; Brethon B; Cario G; Chen-Santel C; Elitzur S; Hazar V; Kunz J; Möricke A; Stein J; Vora A; Yaman Y; Schrappe M; Anak S; Baruche A; Locatelli F; von Stackelberg A; Stanulla M; Bourquin JP
    Haematologica; 2019 Jun; 104(6):e244-e247. PubMed ID: 30765470
    [No Abstract]   [Full Text] [Related]  

  • 56. Kit and Scl regulation of hematopoietic stem cells.
    Rojas-Sutterlin S; Lecuyer E; Hoang T
    Curr Opin Hematol; 2014 Jul; 21(4):256-64. PubMed ID: 24857885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan.
    Imamura T; Kiyokawa N; Kato M; Imai C; Okamoto Y; Yano M; Ohki K; Yamashita Y; Kodama Y; Saito A; Mori M; Ishimaru S; Deguchi T; Hashii Y; Shimomura Y; Hori T; Kato K; Goto H; Ogawa C; Koh K; Taki T; Manabe A; Sato A; Kikuta A; Adachi S; Horibe K; Ohara A; Watanabe A; Kawano Y; Ishii E; Shimada H
    Blood Cancer J; 2016 May; 6(5):e419. PubMed ID: 27176795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties.
    Hunger SP; Li S; Fall MZ; Naumovski L; Cleary ML
    Blood; 1996 Jun; 87(11):4607-17. PubMed ID: 8639829
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
    Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
    Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia.
    Gökbuget N; Zugmaier G; Klinger M; Kufer P; Stelljes M; Viardot A; Horst HA; Neumann S; Brüggemann M; Ottmann OG; Burmeister T; Wessiepe D; Topp MS; Bargou R
    Haematologica; 2017 Apr; 102(4):e132-e135. PubMed ID: 28082340
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.